Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bolt Biotherapeutics Inc (NQ: BOLT ) 0.5655 -0.0569 (-9.14%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Bolt Biotherapeutics Inc < Previous 1 2 3 4 5 Next > SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt July 18, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FutureFuel, SeaStar, and Bolt and Encourages Investors to Contact the Firm July 17, 2024 From Bragar Eagel & Squire Via GlobeNewswire BOLT Stockholders with Large Losses Should Contact Robbins LLP for Information About the Bolt Biotherapeutics, Inc. Class Action Lawsuit July 15, 2024 From Robbins LLP Via Business Wire ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT July 15, 2024 From The Rosen Law Firm PA Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SeaStar and Bolt and Encourages Investors to Contact the Firm July 13, 2024 From Bragar Eagel & Squire Via GlobeNewswire BOLT Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Class Action Against Bolt Biotherapeutics, Inc. July 10, 2024 From Robbins LLP Via GlobeNewswire BOLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bolt Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! July 10, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire BOLT ALERT: Bragar Eagel & Squire, P.C. is Investigating Bolt Biotherapeutics, Inc. on Behalf of Bolt Stockholders and Encourages Investors to Contact the Firm July 09, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT July 08, 2024 From The Rosen Law Firm PA Via GlobeNewswire Bolt Biotherapeutics, Inc. Stockholder Notice: Robbins LLP Reminds Investors of the BOLT Class Action July 08, 2024 From Robbins LLP Via Business Wire ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT July 05, 2024 From The Rosen Law Firm PA Via GlobeNewswire Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against Bolt Biotherapeutics, Inc. (BOLT) July 03, 2024 From Robbins LLP Via GlobeNewswire BOLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bolt Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! July 03, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire ROSEN, A TOP RANKED LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT July 03, 2024 From The Rosen Law Firm, P.A. Via Business Wire The Analyst Anxiety Index: 3 Stocks to Avoid as Uncertainty Grows May 24, 2024 Explore key stocks with analyst uncertainty to avoid amid contrasting global market highs and risky downgrades. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Intraday Session May 15, 2024 Via Benzinga Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 15, 2024 Via Benzinga This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Today May 15, 2024 Via Benzinga Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket May 15, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 15, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday May 15, 2024 We are covering the biggest pre-market stock movers for Wednesday with all of the latest happenings worth watching this morning! Via InvestorPlace BOLT Stock Earnings: Bolt Biotherapeutics Beats EPS, Beats Revenue for Q1 2024 May 14, 2024 BOLT stock results show that Bolt Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session May 14, 2024 Via Benzinga Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team May 14, 2024 From Bolt Biotherapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session April 03, 2024 Via Benzinga BOLT Stock Earnings: Bolt Biotherapeutics Beats EPS, Beats Revenue for Q4 2023 March 21, 2024 BOLT stock results show that Bolt Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. Via InvestorPlace Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update March 21, 2024 From Bolt Biotherapeutics, Inc. Via GlobeNewswire Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference February 27, 2024 From Bolt Biotherapeutics, Inc. Via GlobeNewswire Pacira Appoints Frank D. Lee as Chief Executive Officer December 21, 2023 From Pacira BioSciences Via GlobeNewswire Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu® December 05, 2023 From Bolt Biotherapeutics, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
